Woodward Diversified Capital LLC bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,764 shares of the conglomerate’s stock, valued at approximately $348,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. GHP Investment Advisors Inc. grew its holdings in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 99 shares during the period. Sierra Ocean LLC grew its holdings in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 76 shares during the period. Smallwood Wealth Investment Management LLC acquired a new stake in Danaher during the first quarter worth about $31,000. Dunhill Financial LLC grew its holdings in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 67 shares during the period. Finally, Costello Asset Management INC acquired a new stake in Danaher during the first quarter worth about $41,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Danaher
In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 11.10% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Check Out Our Latest Research Report on DHR
Danaher Stock Performance
NYSE DHR opened at $212.92 on Thursday. The company has a market cap of $152.46 billion, a PE ratio of 45.30, a price-to-earnings-growth ratio of 2.82 and a beta of 0.77. The stock’s 50 day simple moving average is $199.85 and its 200-day simple moving average is $197.42. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.41. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business’s quarterly revenue was up 3.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- What Are Dividend Challengers?
- Datavault AI: The New AI Contender Backed by Big Funding
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- The Basics of Support and Resistance
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.